Dgci
- All
- News
- Videos
-
After Pharma Firm's Huge Eye Drop Claim, Regulator Withdraws Permission
Taking serious note of Mumbai-based Entod Pharmaceuticals' claims that it can help reduce dependency on reading glasses for those suffering from presbyopia, the Drugs Controller General of India (DGCI) has suspended permission given to the company.
-
Cryptocurrency Exchanges Across India Said to Face DGCI Crackdown, Rs. 70-Crore Tax Evasion Detected
After the massive tax evasion of GST by Cryptocurrency Service providers WazirX, the Directorate General of GST Intelligence has come down heavily on Cryptocurrency exchanges operating in the country, said sources.
-
Foreign Vaccines Like Pfizer, Moderna A Step Closer With Key India Waiver
In a big move to clear the way for foreign vaccines like Pfizer and Moderna, the drug regulator has done away with the requirement of India-specific trials.
-
Zydus Cadila's "Virafin" Approved For Treating Moderate Covid Cases
The Drugs Controller General of India (DGCI) has approved emergency use for Zydus Cadila's Pegylated Interferon alpha-2b, "Virafin" for treating moderate COVID-19 infection in adults.
-
Covid Vaccines Being "Analysed Aggressively", Says Minister Amid Key Meet
Applications for the emergency use approval for the coronavirus vaccines filed by the Serum Institute of India, Bharat Biotech and Pfizer are being taken up once again for consideration by a government-appointed panel of experts today.
-
Ready To Restart: Indian Drug Firm After UK Covid Vaccine Trials Resume
The Serum Institute of India (SII) is ready to restart coronavirus vaccine trials - pending permission from the Drug Controller General of India (DGCI) - the manufacturer said in a statement on Saturday evening
-
Central Drug Agency Warns Of Black Marketing Of COVID-19 Drug Remdesivir
The Drug Controller General of India (DGCI) has raised concerns over black marketing and profiteering of Remdesivir, an antiviral drug prescribed for treatment of suspected or severe lab-confirmed cases of COVID-19.
-
Research Body CSIR To Begin Two Drug Trials For COVID-19
The Council for Scientific and Industrial Research (CSIR) has received approval from Drug Controller General of India (DGCI) for its two clinical trial drugs - ''favipiravir'' and ''phytopharmaceutical'' - to combat coronavirus.
-
After Pharma Firm's Huge Eye Drop Claim, Regulator Withdraws Permission
Taking serious note of Mumbai-based Entod Pharmaceuticals' claims that it can help reduce dependency on reading glasses for those suffering from presbyopia, the Drugs Controller General of India (DGCI) has suspended permission given to the company.
-
Cryptocurrency Exchanges Across India Said to Face DGCI Crackdown, Rs. 70-Crore Tax Evasion Detected
After the massive tax evasion of GST by Cryptocurrency Service providers WazirX, the Directorate General of GST Intelligence has come down heavily on Cryptocurrency exchanges operating in the country, said sources.
-
Foreign Vaccines Like Pfizer, Moderna A Step Closer With Key India Waiver
In a big move to clear the way for foreign vaccines like Pfizer and Moderna, the drug regulator has done away with the requirement of India-specific trials.
-
Zydus Cadila's "Virafin" Approved For Treating Moderate Covid Cases
The Drugs Controller General of India (DGCI) has approved emergency use for Zydus Cadila's Pegylated Interferon alpha-2b, "Virafin" for treating moderate COVID-19 infection in adults.
-
Covid Vaccines Being "Analysed Aggressively", Says Minister Amid Key Meet
Applications for the emergency use approval for the coronavirus vaccines filed by the Serum Institute of India, Bharat Biotech and Pfizer are being taken up once again for consideration by a government-appointed panel of experts today.
-
Ready To Restart: Indian Drug Firm After UK Covid Vaccine Trials Resume
The Serum Institute of India (SII) is ready to restart coronavirus vaccine trials - pending permission from the Drug Controller General of India (DGCI) - the manufacturer said in a statement on Saturday evening
-
Central Drug Agency Warns Of Black Marketing Of COVID-19 Drug Remdesivir
The Drug Controller General of India (DGCI) has raised concerns over black marketing and profiteering of Remdesivir, an antiviral drug prescribed for treatment of suspected or severe lab-confirmed cases of COVID-19.
-
Research Body CSIR To Begin Two Drug Trials For COVID-19
The Council for Scientific and Industrial Research (CSIR) has received approval from Drug Controller General of India (DGCI) for its two clinical trial drugs - ''favipiravir'' and ''phytopharmaceutical'' - to combat coronavirus.
